Abstract
A crucial and causative role in the pathogenesis of atherosclerosis is believed to be the oxidative modification of low density lipoprotein (LDL). The oxidation of LDL involves released free radical driven lipid peroxidation. Several lines of evidence support the role of oxidized LDL in atherogenesis. Epidemiologic studies have demonstrated an association between an increased intake of dietary antioxidant vitamins, such as vitamin E and vitamin C and reduced morbidity and mortality from coronary artery diseases. It is thus hypothesized that dietary antioxidants may help prevent the development and progression of atherosclerosis. The oxidation of LDL has been shown to be reduced by antioxidants, and, in animal models, improved antioxidants may offer possibilities for the prevention of atherosclerosis. The results of several on going long randomized intervention trials will provide valuahle information on the efficacy and safety of improved antioxidants in the prevention of atherosclerosis. This review a evaluates current literature involving antioxidants and vascular disease, with a particular focus on the potential mechanisms.
Similar content being viewed by others
References
R. J. Havel, H. A. Eder, and J. H. Bragdon (1995) The distribution and chemical composition of ultracentrifuglly separated lipoproteins in human serum.J. Clin. Invest. 34: 1345–1535.
Stenbrecher, U. P., H. Zhang, and M. Lougheed (1990) Role of oxidatively modified LDL in atherosclerosis.Free Radic. Biol. Med. 9: 155.
Steinverg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Wiztum (1989) Beyond cholesterol: Modifications of low density lipoprotein that increases its atherogenicity.N. Engl. J. Med. 320: 915–924.
Wiztum, J. L. and D. Steinverg (1991) Role of oxidized low density lipoprotein in atherogenesis.J. Clin. Invest. 88: 1985–1972.
Steinvrecher, U. P., H. Zhang, and M. Lougheed (1996) Role of oxidatively modified LDL in atheroscle rosis.Free Radic. Bile. Med. 9: 155–168.
Renaud, D. and M. De Lorgiril (1992) Wine, alcohol, platelets, and the French Paradox for coronary heart disease.Lancet 339: 1523–1525.
Yla-Hertuala, S., W. Palinski, M. E. Rosenfeld, S. Parhasrathy, T. E. Carew, S. Butler, J. L. Wiztum, and D. Steinberg (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J. Clin. Invest. 84: 1086–1095.
Esterbauer, H., J. Gebiki, H. Puhl, and G. Jurgens (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL.Free Radic. Biol. Med. 13: 341–390.
Jiaial, I. and S. M. Grundy (1992) The effect of dietary supplementation with alpha-tocopherol in the oxidative modification of LDL.J. Lipid Res. 33: 889–906.
Verlangieri, A. J., J. C. Kapeghian, S. el-Dean, and M. Bush (1985) Fruit and vegetable consumption and cardiovascular disease mortality.Med. Hypotheses 16: 7–15.
Gey, K. F. and P. Puska (1989) Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology.Ann. NY Acad. Sci. 570: 268–282.
Sinclair, A. J., A. H. Barnett, and J. Lunec (1993) Free radicals and antioxidant systems in health and disease.Br. J. Hosp. Med. 94: 350–356.
Esterbauer, H., H. Puhl, M. Cieber-Rotheneder, G. Waeg, and H. Rabl (1991) Effect of antioxidants on oxidative modification of LDL.Ann. Med. 23: 573.
Esterbauer, H., J. Gebicki, H. Puhl, and G. Jurgens (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL.Free Rad. Biol. Med. 13: 341–390.
Chisolm, G. M. (1991) Cytotoxidity of oxidized lipotroteins.Curr. Opin. Lipidol. 2: 215–232.
Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick (1973) Culture of human endothelial cells derived from human umbilical rein.J. Clin. Invest. 27: 2745–2756.
Yla-Hertuala, S., W. Palinski, D. Steinverg, D. Steinberg, and J. L. Wiztum (1991) Rabbit and human atherosclerotic lesions contain IgG that recognizes MDA-LDL and copper-oxidized LDL.Atherosclerosis 11: 1426–1433.
Avogaro, P., G. Bittolo-Bon, and F. Cazzolato (1998) Pressence of a moditied low density lipoprotein in human.Atherosclerosis 8: 78–97.
Henriksen, T., S. A. Evensen, and B. Carlande (1979) Injury to human endothelial cells in culture induced by low density lipoproteins.Scand. J. Clin. Lib. Invest. 39: 361–370.
Gey, K. D., P. Prska, P. Jordan, and U. K. Moser (1991) Inverse correlation between plasma vitamin E and Mortality from ischemic heart disease in cross-cultural epidemiology.Am. J. Clin. Nutr. 53: 5265–5272.
Riemersas, R. A., D. A. Wood, C. C. A. Macintyre, R. A. Elton, K. F. Gey, and M. F. Oliver (1991) Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.Lancet 337: 1–6.
Trevor-ME, L., A. Chait, W. Raines, and R. Ross (1991) The influence of oxidatirely modified low density lipoproteins on expression of latelet-derived growth factor by human monocyte-derived macrophages.J. Biol. Chem. 226: 18901–18901.
Singh, R. B., M. A. Niaz, S. Chosh, and S. S. Rastogi (1998) Effect on mortality and reinfarction of adding fruits and vegetables to a prudent diet in the Indian experiment of infact Survival.J. Am. Coll. Nutr. 12: 225–261.
Stampfer, M. J., C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett (1993) Vitamin E consumption and the risk of coronary disease in women.N. Engl. J. Med. 328: 1444–1449.
Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett (1993) Vitamin E consumption and the risk of coronary heart disease in men.N. Engl. J. Med. 328: 1450–1456.
Losonczy, K. G., T. B. Harris, and R. J. Havlik (1996) Vitamin E and vitamin, C supplement use and risk of all-cause and coronary beart disease mortality in older persons: The established populations for epidemiologic studies of the elderly.Am. J. Clin. Nutr. 64: 190–196.
Stephens, N. G., A. Parsons, P. M. Schofield, E. Kelly, K. Cheeseman, and M. J. Mitecenson (1996) Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (GHAO).Lancet 347: 781–786.
Jialal, I. and C. Scaccini (1992) Antioxidants and atherosclerosis.Curr. Opin. Lipidol. 3: 324–328.
Ferns, G. A. A., L. Forster, A. Stewart-Lee, M. Konneh, J. Nourooz-Zadeh, and E. E. Anggard (1992) Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit.Proc. Natl. Acad. Sci. USA 89: 11312–11316.
Freyschuss, A., A. Stiko-Rahm, J. Swedenborg, P. Henriksson, I. Bjorkhem, L. Berglund, and J. Nilsson (1993) Anti-oxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbit.J. Clin. Invest. 91: 1282–1288.
Enstrom, J. E., I. E. Kanim, and M. A. Klein (1992) Vitamin C intake and mortality among a sample of the United States population.Epidemiology 3: 194–202.
Lee, Y. J., H. Yamaguchi, H. Daida, H. Yokoi, J. Miyano, J. Takaya, H. Sakurai, and Noma (1991) A PTCA: Pharmacological interventions to modify restenosis.Circulation 84: II-298 (abstr).
Nunes, G. L., D. S. Sgoutas, S. R. Sigman, B. Britt, M. E. Gravanis, King III, and B. C. Berk (1993) Vitamins C and E improve the response to coronary balloon injury in the pig: Effect of vascular remodeling.Circulation 88: 1–372. (abstr).
Porreco, E., S. Ucchino, C. Di Febbo, N. Di Bartolomeo, D. Angelucci, A. M. Napolitano, A. Mezzetti, and F. Cuccutullo (1994) Antiproliferative effect of desferrioxamine on vascular smooth muscle cellsin vitro andin vivo.Athereseler. Thromb. 14: 299–304.
Hirayama, A., S. Nanto, T. Ohara, K. Nishida, Y. Okuyama, and K. Kodama (1992) Preventive effect on restenosis after PTCA by Ebselen: A newly synthesized anti-inflammatory agent.J. Am. Coll. Cardiol. 19: 259 (Abstr).
Lee, B. C. and B. H. Ryu (1997) Antioxidant of silymarin low density lipoprotein on macrophages.Kor. J. Appl. Microbiol. Biotechnol. 25: 286–292.
Ryu, B. H., H. S. Kim, B. C. Lee, and H. S. Lee (1988) Antioxidative effect of lilybin purifiedsilyburu marianum on modification of human low density lipoprotein.Korean J. Life Sci. 8: 35–359.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ryu, B.H. Low density lipoprotein (LDL), atherosclerosis and antioxidants. Biotechnol. Bioprocess Eng. 5, 313–319 (2000). https://doi.org/10.1007/BF02942205
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02942205